News & Updates
Filter by Specialty:
Probiotics may be a promising treatment for depression
Probiotics may be efficacious either as an adjunct to antidepressants or as a standalone treatment for major depressive disorder (MDD), according to results of a meta-analysis and network systematic review.
Probiotics may be a promising treatment for depression
20 Feb 2025
SGLT-2is, GLP-1RAs cut risk of COPD flare-ups
In adults with type 2 diabetes and active chronic obstructive pulmonary disease (COPD), sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) may also reduce the risk of COPD exacerbations, according to a study.
SGLT-2is, GLP-1RAs cut risk of COPD flare-ups
19 Feb 2025
Infliximab trumps other biologics as maintenance drug in CD
Among the many biologics used to treat adults with moderate-to-severe Crohn’s disease (CD), infliximab subcutaneous (SC) 120 mg every 2 weeks (Q2W) demonstrates the highest efficacy in clinical remission during maintenance treatment of 52 to 64 weeks’ duration, according to the results of a recent study presented at CCC 2025.
